Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer

202132 citationsJournal Articlehybrid Open Access

Authors

In the VHA, black men with chemotherapy-naïve mCRPC initiating NHT may have better outcomes than similarly treated white men.

Good health and well-being

Published in: Prostate Cancer and Prostatic Diseases

Volume 25, Issue 3, pp. 524-530

Field-Weighted Citation Impact: 3.53